FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Coordinated Antimicrobial Drug, Test Development Guidance

[ Price : $8.95]

FDA solicits comment on a draft guidance to assist drug sponsors and medical device manufacturers who want to coordinate developme...

Computational Modeling Studies Reporting Guidance

[ Price : $8.95]

FDA issues a guidance on reporting formats for medical device computational modeling and simulation studies.

Alcon Wants Durezol Bioequivalence Requirements

[ Price : $8.95]

Alcon calls on FDA to eliminate the in vitro option for bioequivalence testing for generic Durezol.

Alcon Wants Specific Ciprodex BE Requirements

[ Price : $8.95]

Alcon asks FDA to revise its Ciprodex product-specific guidance to eliminate any in vitro option to demonstrate bioequivalence.

Diabetes Drugs Riskiest to Develop: Tufts Study

[ Price : $8.95]

A Tufts Center for the Study of Drug Development analysis says that FDA review time for diabetes drugs has increased in recent yea...

CDRH Sets 10 Regulatory Science Priorities

[ Price : $8.95]

CDRH publishes 10 regulatory science priorities that will be its focus in FY 2017.

Roundabout Causation in Failure-to-Report Claims: Attorney

[ Price : $8.95]

Reed Smith attorney James Beck reviews cases that explore the legal issues in proving causation in state-law product liability ina...

Lawyers Discuss FDA Bias Concern on Chantix Study

[ Price : $8.95]

Hogan Lovells attorneys say that a CDER briefing document raises a concern that data from a Chantix post-marketing study were comp...

FDA Clears Life Spines Cervical Spacer

[ Price : $8.95]

FDA clears a Life Spine 510(k) for the PRO-LINK Ti Stand-Alone Cervical Spacer System, a stand-alone cervical interbody that is ma...

FDA Accepts Puma NDA for Breast Cancer Therapy

[ Price : $8.95]

FDA accepts for review a Puma Biotechnology NDA for its lead product candidate PB272 (neratinib), indicated for the extended adjuv...